U.S. Logistics Stock News

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...

MoonLake Immunotherapeutics (MLTX) has become a focus for many investors after strong one-year Phase 3 VELA data for sonelokimab in hidradenitis suppurativa and a planned Biologics License Application filing by the end of September. See our latest analysis for MoonLake Immunotherapeutics. That clinical update has come alongside a sharp move in MoonLake Immunotherapeutics’ share price, with a 7-day share price return of 11.80% and a 30-day share price return of 16.66%. However, the 1-year...

Cencora (NYSE:COR) has launched a multi site pilot of its enhanced Nucleus inventory management solution for specialty physician practices. The company also announced an executive transition in the Chief Human Resources Officer role, bringing in a CHRO from another large corporation. Cencora is drawing attention with these linked operational and leadership moves, as investors weigh what they might mean for the business. The stock recently closed at $281.1, with a value score of 6 and long...

American Tower (NYSE:AMT) is expanding its data center operations as demand tied to AI workloads and multicloud deployments increases. The company is emphasizing its role in digital infrastructure that supports cloud computing alongside its traditional tower leasing business. This shift highlights how AI and cloud trends are influencing American Tower's mix of assets and services. For investors used to thinking of American Tower mainly as a tower landlord, the growing focus on data centers...

Quantum Computing Inc. (NasdaqCM:QUBT) has completed its acquisition of NHanced Semiconductors. The deal brings NHanced in as a wholly owned subsidiary of Quantum Computing Inc. The company has launched Fab 2 to support commercial quantum and photonic hardware production. For Quantum Computing Inc., this acquisition is a significant move into chip manufacturing and advanced packaging, which sit at the heart of quantum and photonic hardware. As more computing workloads push into areas like...

Definium Therapeutics (NasdaqGS:DFTX) reported positive topline Phase 3 results for DT120 in major depressive disorder. The company completed a US$700 million follow on equity offering to fund regulatory and commercialization plans for DT120. The latest data readout and capital raise were announced together as Definium Therapeutics positions DT120 for potential market entry. Definium Therapeutics focuses on treatments for psychiatric conditions, with DT120 targeting major depressive...

CRH stock snapshot and recent returns CRH (NYSE:CRH) has drawn investor interest after a mixed run in its share price, with the stock down about 0.9% on the day and 2.3% over the past week. Over the past month, CRH has gained roughly 9.9%, while its total return over the past 3 months is about 4%. Year to date, the stock is down around 12.8%, yet its 1 year total return stands near 21.9%. See our latest analysis for CRH. CRH’s recent pullback in its share price, with a year to date share...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies with strong innovation and scalability potential that can thrive despite short-term market fluctuations.

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 21% over the past year, with earnings forecasted to grow by 19% annually. In this context, identifying stocks that may be trading below their fair value can present opportunities for investors seeking to capitalize on potential growth and resilience in a fluctuating market environment.

From what we can see, insiders were net buyers in System1, Inc.'s ( NYSE:SST ) during the past 12 months. That is...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings forecasted to grow by 19% annually. In this context of fluctuating market conditions, companies with high insider ownership can often signal strong confidence in future growth prospects, making them appealing considerations for investors seeking robust opportunities.

Over the last 7 days, the U.S. market has dropped 2.3%, but it is up 21% over the past year with earnings forecasted to grow by 19% annually. In light of these conditions, identifying stocks with strong fundamentals and growth potential can be key to navigating market fluctuations. Penny stocks, though an older term, still represent a viable investment area; they often involve smaller or newer companies that offer unique growth opportunities at lower price points.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains robust with a 21% increase over the past year and an earnings forecast predicting a 19% annual growth. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer unique opportunities for investors seeking to capitalize on these positive trends.

Over the last 7 days, the United States market has dropped 2.3%, though it remains up by 21% over the past year, with earnings forecasted to grow by 19% annually. In this dynamic environment, identifying strong dividend stocks can be an effective strategy for investors seeking stability and income amidst fluctuating market conditions.

BTCS Inc.'s (NASDAQ:BTCS) value has fallen 10% in the last week, but insiders who sold US$1.3m worth of stock over the...

Electricity demand is climbing as data centers, AI workloads, and electrification plans put extra pressure on already stretched grids. At the same time, supply risks in key energy chokepoints are pushing governments and utilities to focus more on resilient, flexible power systems. That mix of higher demand and energy security concerns is pulling attention toward companies exposed to grid equipment, transmission, metering, substation technology, and energy storage. This article walks through 3...

In June 2026, Getty Images announced a multi-year display agreement with OpenAI that will integrate its licensed visual content libraries into ChatGPT’s search and discovery features, enriching on-platform visual responses with authenticated imagery. This move places Getty Images’ rights-cleared library at the heart of one of the world’s most widely used AI interfaces, highlighting how licensed content can underpin more trustworthy visual AI experiences. We’ll now examine how this OpenAI...

Flutter Entertainment plans to delist from the London Stock Exchange and move to a sole NYSE listing under ticker NYSE:FLUT. The company outlined the intention following a review of trading activity and regulatory considerations. The decision marks a structural shift in how Flutter Entertainment engages with public markets and its shareholder base. Flutter Entertainment is set to concentrate its listing in the US market, with NYSE:FLUT becoming its primary trading venue. The move comes at a...

Primoris Services (NYSE:PRIM) sharply cut its 2026 profit and renewables revenue guidance. The company reported persistent cost overruns and project delays in its Renewables segment. Primoris Services announced the sudden departure of its Chief Operating Officer. Multiple law firms have launched investigations following a steep share price drop. Primoris Services (NYSE:PRIM) is under pressure after a sharp reset to its 2026 earnings outlook and renewables revenue guidance, combined with the...

uniQure (NasdaqGS:QURE) reported positive initial data from its Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy. Several patients in the initial low dose cohort experienced meaningful seizure reduction, with an encouraging safety profile. This is the first clinical efficacy and safety readout for AMT-260, expanding uniQure's pipeline beyond Huntington's disease. uniQure, trading at $49.04, is drawing fresh attention as AMT-260 moves from concept to early clinical...

Talphera, Inc. ( NASDAQ:TLPH ) insiders who bought shares over the past year were rewarded handsomely last week. The...

Insiders who acquired US$611.2k worth of Sintx Technologies, Inc.'s ( NASDAQ:SINT ) stock at an average price of...

Last week, DiaMedica Therapeutics Inc. ( NASDAQ:DMAC ) insiders, who had purchased shares in the previous 12 months...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...